Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial-Reference-Cited by-同舟云学术

Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial

Published:2019-11 Issue:11 Volume:30 Page:1776-1783
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bartlett J.M.S.,Sgroi D.C.,Treuner K.,Zhang Y.,Ahmed I.,Piper T.,Salunga R.,Brachtel E.F.,Pirrie S.J.,Schnabel C.A.,Rea D.W.

Funder

Biotheranostics, Inc.

Breast Cancer Research Foundation

Ontario Institute for Cancer Research

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz289/30043607/mdz289.pdf

Reference30 articles.

1. Evolution of targeted therapy in breast cancer: where precision medicine began;Meisel;Am Soc Clin Oncol Educ Book,2018

2. Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial;Bartlett;J Clin Oncol,2011

3. Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials;Regan;Breast Cancer Res Treat,2015

4. Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial;Dowsett;J Clin Oncol,2008

5. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,2011

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer;JAMA Oncology;2024-08-15

2. ERBB2/HOXB13co-amplification with interstitial deletion ofBRCA1defines a unique subset of breast cancers;2024-08-07

3. 15-Year Survival Outcome of Primary Breast Conservation Therapy in Young Women with Breast Cancer;Indian Journal of Surgical Oncology;2024-08-06

4. Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up;Acta Oncologica;2024-07-05

5. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07